Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT05891028
Overview
Positron labeled camptothecin based PET imaging is a new imaging technique that uses positron isotopes such as 68Ga/64Cu for PET/CT (MR) imaging. It is expected to have significant clinical significance in staging and detecting primary and metastatic head and neck cancer, oral cancer, and colorectal cancer tumors.
Phase
Early Phase 1
Contacts
Rongxi Wang
zhzwrx.123@163.com
+8615584172170
Zhaohui Zhu (Study Chair)
pumch_jacobwong@163.com
+8619800370331
ClinicalTrials.gov
NCT05891028Help us improve your experience